- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01838629
the Effect of Universal Salt Iodization on Thyroid Diseases
May 4, 2013 updated by: Weimin Xu
- acquire the environmental iodine status of Hangzhou
- acquire the iodine status of population in Hangzhou
- acquire the prevalence of thyroid diseases in Hangzhou
- explore the association between iodized salt and thyroid disease
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
12438
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- Hangzhou Center of Disease Control and Prevention
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 86 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
This study was conducted in Hangzhou, Zhejiang Province, China, which locates at east of China.
This city covers eight districts and five counties.
There are 8.7 millions residents in Hangzhou city; 73.25% of them living in urban areas, 26.75% in rural areas.
This study was designed to be representative of the civilian from Hangzhou and collected information on demographic characteristics, health status, iodine intake and thyroid disease.
Description
Inclusion Criteria:
- age ≥ 6 years old;
- living for above 5 years at present residence.
Exclusion Criteria:
- resident with coronary angiography (CAG) or endoscopic retrograde cholangiopancreatography (ERCP) in 6 months;
- resident taking amiodarone drug;
- resident with abnormal kidney function or serious illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
thyroid nodule
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
thyroid nodule
Time Frame: 8:00am (day 1)
|
An ultrasound examination of the thyroid was performed to detect thyroid nodules, using a Sonoline Versa Pro (Siemens, Munich, Germany) with a 7.5-MHz, 70-mm linear transducer (effective length, 62 mm).
|
8:00am (day 1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Weimin Xu, Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang, China
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Xu W, Chen Z, Li N, Liu H, Huo L, Huang Y, Jin X, Deng J, Zhu S, Zhang S, Yu Y. Relationship of anthropometric measurements to thyroid nodules in a Chinese population. BMJ Open. 2015 Dec 21;5(12):e008452. doi: 10.1136/bmjopen-2015-008452.
- Chen Z, Xu W, Huang Y, Jin X, Deng J, Zhu S, Liu H, Zhang S, Yu Y. Associations of noniodized salt and thyroid nodule among the Chinese population: a large cross-sectional study. Am J Clin Nutr. 2013 Sep;98(3):684-92. doi: 10.3945/ajcn.112.054353. Epub 2013 Jul 10.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2009
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
April 19, 2013
First Submitted That Met QC Criteria
April 23, 2013
First Posted (Estimate)
April 24, 2013
Study Record Updates
Last Update Posted (Estimate)
May 7, 2013
Last Update Submitted That Met QC Criteria
May 4, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20090833B27
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Nodule
-
Tseung Kwan O Hospital, Hong KongRecruitingBenign Thyroid Nodule | Suspicious Malignant Thyroid NoduleHong Kong
-
Brigham and Women's HospitalHarvard School of Public Health (HSPH); Agency for Healthcare Research and...Active, not recruitingThyroid Cancer | Thyroid Nodule (Benign) | Thyroid Nodule (Diagnosis)United States
-
University Hospital, GhentUniversitaire Ziekenhuizen KU Leuven; AZ Sint-Jan AVRecruitingBenign Thyroid NoduleBelgium
-
Suez UniversityNot yet recruiting
-
Minia UniversityCompletedBenign Thyroid NoduleEgypt
-
Rijnstate HospitalZonMw: The Netherlands Organisation for Health Research and Development; University... and other collaboratorsTerminatedRadiofrequency Ablation | Thyroid Nodule, Toxic or With Hyperthyroidism | Autonomous Thyroid Function | Thyroid Nodule; Hyperthyroidism | Iodine Hyperthyroidism | Iodine Adverse ReactionNetherlands
-
Imperial College LondonActive, not recruitingThyroid Cancer | Nodule Solitary ThyroidUnited Kingdom
-
Aarhus University HospitalOdense University Hospital; University of AarhusActive, not recruitingThyroid Cancer | Thyroid Nodule (Diagnosis)Denmark
-
Insel Gruppe AG, University Hospital BernRecruitingThyroid Nodule (Diagnosis)Switzerland
-
Pulse Biosciences, Inc.CompletedThyroid Nodule (Benign)Italy